As of Sep 20
| -0.20 / -0.35%|
The 2 analysts offering 12-month price forecasts for USANA Health Sciences Inc have a median target of 70.50, with a high estimate of 71.00 and a low estimate of 70.00. The median estimate represents a +23.36% increase from the last price of 57.15.
The current consensus among 2 polled investment analysts is to Buy stock in USANA Health Sciences Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.